Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Capital Employed (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Return on Capital Employed for 11 consecutive years, with 0.37% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 31.0% to 0.37% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.37% through Dec 2025, up 31.0% year-over-year, with the annual reading at 0.57% for FY2025, 67.0% up from the prior year.
  • Return on Capital Employed hit 0.37% in Q4 2025 for vTv Therapeutics, up from 0.56% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.37% in Q4 2025 to a low of 10.84% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 1.55% across 5 years, with a median of 0.92% in 2021.
  • Biggest YoY gain for Return on Capital Employed was 3668bps in 2021; the steepest drop was -1012bps in 2021.
  • Year by year, Return on Capital Employed stood at 1.09% in 2021, then rose by 22bps to 0.85% in 2022, then tumbled by -1183bps to 10.84% in 2023, then surged by 94bps to 0.68% in 2024, then surged by 45bps to 0.37% in 2025.
  • Business Quant data shows Return on Capital Employed for VTVT at 0.37% in Q4 2025, 0.56% in Q3 2025, and 1.07% in Q2 2025.